Phreesia(US:PHR) Financial Modeling Prepยท2025-09-08 17:02Core Viewpoint - Phreesia, Inc. is a healthcare technology company focused on enhancing patient intake management solutions, aiming to improve patient engagement and operational efficiency in the healthcare sector [1]. Financial Performance - Phreesia reported earnings of 1 cent per share for the second quarter, exceeding market expectations of a 6-cent loss per share [3]. - The company's quarterly sales reached $117.3 million, slightly above the anticipated $116.5 million [3]. - Phreesia has reaffirmed its fiscal year 2026 sales guidance, projecting sales between $472 million and $482 million, compared to market estimates of $477.1 million [5]. Market Reaction - Despite reporting a net income positive quarter for the first time, Phreesia's shares fell by 8.5%, indicating a mixed market reaction to the company's progress [4]. - Truist Financial set a price target of $36 for Phreesia, suggesting a potential price increase of about 28% from its current price of $28.13, despite a recent decline of approximately 9.87% [2][6]. Company Milestones - CEO Chaim Indig highlighted the significance of achieving the first-ever net income positive quarter and the acquisition of AccessOne, positioning Phreesia for future growth [4]. - The company's market capitalization stands at approximately $1.67 billion, with a trading volume of 2,671,494 shares [5].